Nanotechnology in neuroscience and neuroengineering

Neuroengineering focuses on the development of artificial devices and novel materials to be functionally and structurally interfaced with the central nervous system (CNS). Today, there is the expectation that materials science and nanotechnology will be able to address these challenges and lead to breakthroughs at the level of the interfaces between artificial transducers/actuators and living cells. Nanoparticles are able to penetrate the BBB of in vitro and in vivo models; and therefore can be used to develop diagnostic tools as well as nano-enabled delivery systems that can bypass the BBB in order to facilitate conventional and novel neurotherapeutic interventions such as drug therapy, gene therapy, and tissue regeneration.

 

  • Advances in the treatment of lewd body dementia disease with nanoparticle
  • Advances in the treatment of Parkinson’s disease with nanoparticle
  • Up-take mechanisms of nanoparticles into brain
  • Advances in the treatment of frontotemporal disease with nanoparticle
  • Advances in the treatment of huntington disease with nanoparticle
  • Advances in the treatment of Alzheimer’s disease with nanoparticle
  • Advances in the treatment of vascular dementia disease with nanoparticle
  • Current and future development

Related Conference of Nanotechnology in neuroscience and neuroengineering

July 22-23, 2019

35th World Congress on Materials Science and Nanotechnology

Melbourne, Australia
21-22 October 2019

25th World Congress on Advanced Materials

Singapore
November 18-19, 2019 Rome, Italy

36th Global Conference on Smart and Nano Materials

February 24-25, 2020

5th Annual Conference and Expo on Biomaterials

Berlin, Germany

Nanotechnology in neuroscience and neuroengineering Conference Speakers

Recommended Sessions

Related Journals

Are you interested in